Table 1.

Lats1 is identified as a putative target of p110 CUX1 in 8 cell lines

HEL	4.3E-11
K562	3.5E-9
U266	1.5E-3
Ramos	4.0E-4
Hs578T	3.5E-7
HeLa	1.6E-4
293	1.5E-8
RPMI	5.7E-6

Genome-wide location analysis was performed using a panel of 8 human cell lines of various cell types: breast tumor (Hs578T), cervical carcinoma (HeLa), kidney epithelial (HEK293), myeloid leukemia (K562, HEL), and B cell lymphoma (Ramos, U266, RPMI8266). For each cell line, hybridization experiments were done in triplicate using three independent ChAP-enriched and input DNA samples (8 cell lines × 3 hybridizations = 24). ChAP-enriched DNA regions associated with p110 CUX1 were purified and labeled with Cy5 dye. Equal amounts of Cy5-labeled ChAP products and Cy3-labeled input DNA samples were co-hybridized onto a human genomic DNA microarray containing the region spanning 800 bp upstream and 200 bp downstream of transcription start sites of 18,660 human genes. P values observed for the Lats1 promoter are shown. The data is taken from [35].